Debt Financing - MPC Therapeutics
Investment Firm
Overview
MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.
Announced Date
Nov 16, 2023
Funding Type
Debt Financing
Highlights
Location
Switzerland, Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
MPC Therapeutics raised $112544 on 2023-11-16 in Debt Financing
MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 01, 2019 |  Grant - MPC Therapeutics | 1 | - | 658.3K |
| Nov 01, 2020 | Grant - MPC Therapeutics | - | 180.0K | |
| Jan 10, 2023 | Seed Round - MPC Therapeutics | 1 | - | 1.6M |
| Nov 16, 2023 | Debt Financing - MPC Therapeutics | 1 | - | 112.5K |
Recent Activity
There is no recent news or activity for this profile.